Cooper Companies | COO - Assets

Stock Price
64.42
Daily Change
-0.53 -0.82%
Monthly
-9.84%
Yearly
-20.36%
Q2 Forecast
63.04

Cooper Companies reported $12.42B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Align Technology USD 6.23B 141K Dec/2025
AtriCure USD 654.18M 18.74M Dec/2025
Avanos Medical USD 1.07B 6M Dec/2025
Bausch Health Companies USD 26.37B 458M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Dentsply International USD 5.43B 224M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.7B 425M Dec/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Haemonetics USD 2.49B 48.73M Dec/2025
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
Intuitive Surgical USD 20.11B 347.7M Mar/2026
J&J USD 200.89B 1.68B Mar/2026
Medtronic USD 91.48B 139M Dec/2025
Merit Medical Systems USD 2.69B 54.92M Dec/2025
Novartis USD 110.95B 3.66B Dec/2025
ResMed USD 8.5B 195.02M Dec/2025
STAAR Surgical USD 451.68M 4.68M Dec/2025
Steris USD 10.59B 180.7M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Utah Medical Products USD 122.54M 567K Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025